The world is changing,
and so are we.

Volpara Solutions is now Volpara Health.

At Volpara, we’re on a mission to prevent advanced-stage cancer. By combining our ground breaking Breast Health Platform with empowered patients, we are unleashing a revolution in cancer detection.

Check back for exciting updates to our website.

VolparaEnterprise software provides ConstantQuality metrics and breast-specific key performance indicators to help your team perform at its very best, delivering the highest-quality breast imaging services.

Learn more about VolparaEnterprise

VolparaEnterprise Clinical Applications provide quick, automated assessment of every exam, producing a Volpara Scorecard that includes VolparaDensity, VolparaDose, and VolparaPressure.

Learn more about VolparaEnterprise DDP

VolparaDensity provides fast, objective assessment of a woman’s breast density from most digital mammography and tomosynthesis vendors.

Learn more about VolparaDensity

About Volpara Health

Volpara Health is the wholly-owned sales and marketing arm of Volpara Health Technologies Limited – an ISO13485 and ISO27001 certified, ISO14971, FDA GMP compliant research, development and manufacturing company that develops digital health solutions to enable personalized, high-quality breast cancer screening based on objective measurements of breast density, compression and radiation dose.

~10,000,000
Women Benefiting
300
Research Publications
~2,000
US Facilities
38
Countries

Researching? Check out our Science Hub

Volpara is the tool of choice for many researchers around the world. The Volpara suite of products provides ongoing information for improving clinical screening to population characteristics and breast cancer risk.

Upcoming Events

AHRA, 2020

Virtual, August 11-13th

Contact us for a demo